Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Mallinckrodt
McKinsey
Covington
Moodys
Federal Trade Commission
Cipla
Harvard Business School
Cerilliant

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020036

« Back to Dashboard

NDA 020036 describes AREDIA, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the AREDIA profile page.

The generic ingredient in AREDIA is pamidronate disodium. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the pamidronate disodium profile page.
Summary for 020036
Tradename:AREDIA
Applicant:Novartis
Ingredient:pamidronate disodium
Patents:0
Therapeutic Class:Metabolic Bone Disease Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength30MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Oct 31, 1991TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength60MG/VIAL
Approval Date:May 6, 1993TE:RLD:No

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength90MG/VIAL
Approval Date:May 6, 1993TE:RLD:No

Expired US Patents for NDA 020036

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-003 May 6, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-003 May 6, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-004 May 6, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis AREDIA pamidronate disodium INJECTABLE;INJECTION 020036-001 Oct 31, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
Daiichi Sankyo
Citi
US Army
Federal Trade Commission
Moodys
Medtronic
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.